LY4064912 Clinical Trials (2026): 1 Studies for Healthy & Overweight or Obesity
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 LY4064912 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy & Overweight or Obesity) and 144 total planned enrollment. 1 LY4064912 clinical trial is actively recruiting at 2 U.S. sites across 2 states. Most recent activity: NCT07152002 (Nov 2026).
Where to Participate: All LY4064912 Trial Sites in the U.S. (2 sites across 2 states)
Every actively recruiting LY4064912trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Collaborative Neuroscience Network - CNS | Los Alamitos90720 | NCT07152002 | Map |
| TX | ICON Early Phase Services | San Antonio78209 | NCT07152002 | Map |
LY4064912 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting LY4064912 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07152002 | YHAAA Study of LY4064912 in Healthy Participants and With Overweight or Obesity | P1 | Overweight or Obesity | 144 | Aug 2025 |
All LY4064912 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07152002 | YHAA | A Study of LY4064912 in Healthy Participants and With Overweight or Obesity | P1 | recruiting | 144 | Eli Lilly and Company | Aug 2025 |
LY4064912 clinical trials: frequently asked questions
- How many LY4064912 clinical trials are there?
- 1 LY4064912 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are LY4064912 clinical trials recruiting in 2026?
- Yes — 1 LY4064912 trial is actively recruiting in 2026, with 2 U.S. sites across 2 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is LY4064912 being studied for?
- LY4064912 is being studied for Healthy, Overweight or Obesity. The trials are grouped by indication on this page.
- What phase is LY4064912 in?
- LY4064912 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors LY4064912 clinical trials?
- The lead sponsor across the most LY4064912 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY4064912as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: